Form 4 Tracker
HALOZYME THERAPEUTICS, INC.
HALO

25 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 13, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
10,000$69.19$691.9K767,780(D)

View →

May 12, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$71.75$1.4M767,780(D)

View →

May 11, 2026May 13 9:50 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$65.35$1.3M767,780(D)

View →

May 11, 2026May 11 8:10 PMHelen Torley
Proposed Sale
101,923$64.12$6.5M

View →

May 1, 2026May 5 9:05 PMBernadette ConnaughtonDirector
Sale
1,625$63.48$103.2K38,498(D)

View →

May 1, 2026May 1 8:45 PMBERNADETTE CONNAUGHTON
Proposed Sale
4,875$63.66$310.3K

View →

Apr 6, 2026Apr 7 9:13 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
10,000$63.50$635.0K767,780(D)

View →

Apr 2, 2026Apr 2 10:28 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$64.24$1.3M767,780(D)

View →

Apr 1, 2026Apr 2 10:28 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$65.38$1.3M767,780(D)

View →

Mar 10, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Sale
8,857$67.64$599.1K7,055(D)

View →

Mar 9, 2026Mar 10 11:18 PMCortney CaudillSVP, CHIEF OPERATING OFFICER
Sale
20,000$67.80$1.4M14,366(D)

View →

Mar 10, 2026Mar 10 8:05 PMCORTNEY A CAUDILL
Proposed Sale
8,857$67.64$599.1K

View →

Mar 9, 2026Mar 9 8:18 PMCORTNEY A CAUDILL
Proposed Sale
20,000$67.80$1.4M

View →

Mar 4, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
10,000$70.21$702.1K767,780(D)

View →

Mar 3, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$69.01$1.4M767,780(D)

View →

Mar 2, 2026Mar 4 11:56 PMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$69.69$1.4M767,780(D)

View →

Feb 5, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
10,000$78.64$786.4K708,719(D)

View →

Feb 4, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$77.24$1.5M708,719(D)

View →

Feb 3, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Sale
20,000$76.12$1.5M708,719(D)

View →

Feb 3, 2026Feb 3 9:17 PMHelen Torley
Proposed Sale
150,000$74.45$11.2M

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 20, 2026Feb 24 11:16 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
6,688$0.0036,357(D)

View →

Feb 20, 2026Feb 24 11:14 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
5,332$0.0015,995(D)

View →

Feb 23, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
22,436$0.0044,872(D)

View →

Feb 20, 2026Feb 24 11:12 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
16,757$0.0050,270(D)

View →

Feb 16, 2026Feb 17 11:53 PMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Option Exercise
16,812$0.000(D)

View →

Feb 16, 2026Feb 17 11:52 PMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Option Exercise
23,773$0.000(D)

View →

Feb 16, 2026Feb 17 11:51 PMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
89,055$0.000(D)

View →

Feb 9, 2026Feb 12 2:21 AMCortney CaudillSVP, CHIEF OPERATING OFFICER
Grant/Award
44,248$80.4814,751(D)

View →

Feb 9, 2026Feb 12 2:20 AMMark Howard SnyderSVP, CHIEF LEGAL OFFICER
Grant/Award
78,087$80.4829,502(D)

View →

Feb 9, 2026Feb 12 2:20 AMNicole LabrosseSVP, CHIEF FINANCIAL OFFICER
Grant/Award
42,117$0.0029,502(D)

View →

Feb 9, 2026Feb 12 1:56 AMHelen TorleyDirector, PRESIDENT AND CEO
Grant/Award
241,366$80.4892,714(D)

View →

Feb 5, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
10,000$12.07201,923(D)

View →

Feb 4, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07211,923(D)

View →

Feb 3, 2026Feb 6 12:38 AMHelen TorleyDirector, PRESIDENT AND CEO
Option Exercise
20,000$12.07231,923(D)

View →

← Previous

Page 2 of 2